CFA
BIVV

Carroll Financial Associates’s Bioverativ Inc. Common Stock BIVV Stock Holding History

Carroll Financial Associates’s Portfolio BIVV Stock Details BIVV Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2018
Q1 		– Sell
-230
Closed -$12K – 1387
2017
Q4 		$12K Hold
230
– – ﹤0.01% 792
2017
Q3 		$13K Sell
230
-6
-3% -$351 ﹤0.01% 769
2017
Q2 		$14K Buy
+236
New +$13.4K ﹤0.01% 771

Other funds holding BIVV

IA
IFP Advisors Tampa, Florida $5.54B AUM 27.43% 1-Year Est. Return
ACS
Archford Capital Strategies Swansea, Illinois $987M AUM 29.31% 1-Year Est. Return

Carroll Financial Associates's BIVV Position: Q1 2018 in Review

Carroll Financial Associates sold out of Bioverativ Inc. Common Stock (BIVV) in Q1 2018, closing a stake of 230 shares — an estimated $12K sold.

Carroll Financial Associates first reported a position in BIVV in Q2 2017 and held it in 3 quarters. The position peaked at $14K in Q2 2017. 2 funds tracked by Wall St. Rank hold BIVV as of Q1 2018.

  • Carroll Financial Associates reported no remaining Bioverativ Inc. Common Stock position as of Q1 2018 after selling out during the quarter.
  • Carroll Financial Associates sold 230 Bioverativ Inc. Common Stock shares in Q1 2018, an estimated $12K.
  • Carroll Financial Associates first reported a position in Bioverativ Inc. Common Stock in Q2 2017 and held it in 3 quarters.
  • Carroll Financial Associates's Bioverativ Inc. Common Stock position peaked at $14K in Q2 2017.
  • 2 funds tracked by Wall St. Rank held Bioverativ Inc. Common Stock as of Q1 2018.

Based on Carroll Financial Associates's 13F filing for Q1 2018, filed 6 Apr 2018.